| Product NDC: | 0074-3799 |
| Proprietary Name: | Humira |
| Non Proprietary Name: | Adalimumab |
| Active Ingredient(s): | & nbsp; Adalimumab |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0074-3799 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125057 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20110405 |
| Package NDC: | 0074-3799-02 |
| Package Description: | 2 KIT in 1 CARTON (0074-3799-02) > 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY > .8 mL in 1 SYRINGE * 1 SWAB in 1 PACKET |
| NDC Code | 0074-3799-02 |
| Proprietary Name | Humira |
| Package Description | 2 KIT in 1 CARTON (0074-3799-02) > 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY > .8 mL in 1 SYRINGE * 1 SWAB in 1 PACKET |
| Product NDC | 0074-3799 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Adalimumab |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20110405 |
| Marketing Category Name | BLA |
| Labeler Name | AbbVie Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |